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Abstract Pathology reporting is evolving from a traditional
narrative report to a more structured synoptic report. Narrative
reporting can cause misinterpretation due to lack of informa-
tion and structure. In this systematic review, we evaluate the
impact of synoptic reporting on completeness of pathology
reports and quality of pathology evaluation for solid tumours.
Pubmed, Embase and Cochrane databases were systematical-
ly searched to identify studies describing the effect of synoptic
reporting implementation on completeness of reporting and
quality of pathology evaluation of solid malignant tumours.
Thirty-three studies met the inclusion criteria. All studies, ex-
cept one, reported an increased overall completeness of pa-
thology reports after introduction of synoptic reporting (SR).
Most frequently studied cancers were breast (n = 9) and colo-
rectal cancer (n = 16). For breast cancer, narrative reports
adequately described ‘tumour type’ and ‘nodal status’.
Synoptic reporting resulted in improved description of ‘resec-
tion margins’, ‘DCIS size’, ‘location’ and ‘presence of
calcifications’. For colorectal cancer, narrative reports ade-
quately reported ‘tumour type’, ‘invasion depth’, ‘lymph node
counts’ and ‘nodal status’. Synoptic reporting resulted in in-
creased reporting of ‘circumferential margin’, ‘resection mar-
gin’, ‘perineural invasion’ and ‘lymphovascular invasion’. In
addition, increased numbers of reported lymph nodes were
found in synoptic reports. Narrative reports of other cancer
types described the traditional parameters adequately, whereas
for ‘resection margins’ and ‘(lympho)vascular/perineural inva-
sion’, implementation of synoptic reporting was necessary.
Synoptic reporting results in improved reporting of clinical
relevant data. Demonstration of clinical impact of this im-
provedmethod of pathology reporting is required for successful
introduction and implementation in daily pathology practice.
Keywords Pathology . Synoptic reporting . Narrative
reporting . Checklist . Template . Proforma . Guideline .
Completeness . Quality . Colorectal carcinoma .Breast cancer
Introduction
The ever increasing complexity of cancer treatment requires a
high-quality diagnostic process, in which anatomic pathology
plays a central role. A complete and clear anatomic pathology
report forms the basis for optimal treatment decisions [1].
Depending on cancer type, an increasing number of parame-
ters need to be reported by pathologists [2–5].
The way anatomic pathology reports are constructed
needs to adapt to the continuous increase in complexity
of reported diagnostic data [6]. There is a spectrum in
the way pathology results are reported. This spectrum is
divided into six levels by Srigley et al. [6]. Traditionally,
a report consists of the following three paragraphs:
macroscopy, microscopy and conclusion all completed
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with free text and without any further guidelines. These
traditional narrative pathology reports (NRs) are consid-
ered level 1 reporting. NRs are still the standard in most
jurisdictions, even though they are prone to misinterpre-
tation [7] and do not always contain all mandatory infor-
mation [8–16]. Level three consists of a synoptic-like
structured format. With this method, the pathologist fol-
lows a checklist per cancer type to ensure that all man-
datory parameters are reported. The layout of this type of
reporting can still be narrative. More recently, synoptic
reporting (SR) has been introduced in pathology. With
SR, an electronic reporting module is used with
standardised reporting language, multiple-choice answer-
ing of mandatory pathology parameters and automated
generation of the conclusion (such as TNM stage).
Generating a diagnostic report using such a system is
much more comparable to filling out a form in an inter-
net browser than it is to narrative reporting using speech
recognition software. The result is a well-structured over-
view of the mandatory parameters for the pathology re-
port (level 6). All levels are described in detail by
Srigley et al. [6].
SR has been implemented in several settings all over
the world [17]. However, an overview of the effect of SR
on the completeness of pathology reports and quality of
pathology evaluation in cancer diagnosis is lacking. In
the current review, we evaluated the impact of the intro-
duction of SR. We hypothesised that the implementation
of SR improved both the completeness of anatomic pa-
thology reports (per parameter and overall) as well as the
inherent quality of anatomic pathologic evaluation of
cancer specimens.
Materials and methods
To identify studies that described the effect of SR on com-
pleteness of reporting and quality of pathology evaluation of
solid malignant tumours, a systematic literature search was
performed.
Literature search
A combination of search terms in Pubmed, Embase and
Cochrane was used to perform the literature search. For the
search, we included variations of the following terms: ‘synop-
tic’, ‘checklist’, ‘template’, ‘pathologic’, ‘histopathology’ and
‘report’. In addition, reference lists of selected papers were
manually searched (Online resource 1 describes the search
terms in detail). The literature search was performed on
September 30, 2015.
Studies were included if studies investigated human
subjects, pathology, solid tumours, SR and histology.
Selection was first based on title and subsequently on
abstract. Only original studies evaluating the effect of
SR versus NR of solid malignant tumours were selected.
(Conference) abstracts, case reports, editorials, letters and
studies for which the full text was not available were
excluded. Only studies describing quantitative outcomes
of the comparison of SR with NR were included.
Therefore, we excluded studies that only described a for-
mat of pathology reporting before implementation of SR
that described the development of a SR module or the
implementation strategy for SR. Two independent inves-
tigators (CS and LvL) reviewed each full text report for
eligibility.
From each included article, data was extracted on country
of study, year and period of study, study design, cancer type,
level of reporting before and after the implementation of SR
[6], origin of guideline on which the synoptic data parameters
are based, outcome measures, results and authors’ conclusion.
The format or level of SR as described by Srigley et al. [6] was
determined to categorise the studies.
Outcome measures
The outcome measures evaluated in this systematic review
were completeness of the pathology reports and the quality
of pathology evaluation. We used two definitions for com-
pleteness of pathology reports: (1) overall completeness, the
proportion of pathology reports containing all mandatory pa-
thology parameters in a given time frame, and (2) parameter-
specific completeness, the proportion of pathology reports in
which an individual parameter was present in a given time
frame. Both definitions were applied to the selected studies.
Quality of pathology evaluation was defined as the propor-
tion of pathology reports in which the informational content
corresponds to established quality indicators, such as lymph
node numbers, presence of extramural vascular invasion and
resection margins.
Data evaluation
The studies were categorised based on cancer type and the
implemented level of SR (level 3 versus ≥level 4). To compare
completeness, absolute numerical data in studies were con-
verted into percentages. We included parameters that were
reported in at least two independent studies. For readability,
in the tables, we included only parameters that were reported
in at least three independent studies. There is no established
definition for sufficient reporting of a parameter. We consid-
ered a parameter sufficiently reported if the proportion of pa-
thology reports containing the parameter was greater than
90 % in all the studies that studied the parameter, per cancer
type. This percentage was based on definitions used in a num-
ber of other studies [18–22].
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Results
A total of 3252 potentially relevant studies were retrieved by
the database search. After removing duplicates, 2338 studies
remained (Fig. 1). We excluded 2156 studies based on title,
another 111 studies based on abstract or full text and 38 studies
because the full-text article was not available. The remaining 33
studies were included for this review [6, 18–21, 23–52].
Characteristics of studies
Table 1 summarises the characteristics of the 33 included stud-
ies. Twenty-three studies had a cross-sectional design and ten
a case-control design. The studies originated from the follow-
ing countries: the UK (n = 7), Australia (n = 6), Canada
(n = 5), the USA (n = 4), Norway (n = 4), Germany (n = 2),
the Czech Republic, Ireland, Italy, Sri Lanka and Sweden (all
n = 1). Ten different types of cancer were covered in the
studies. Most covered cancer types were colorectal (n = 16),
breast (n = 9) and prostate cancers (n = 6). Twenty-three out of
the 33 studies implemented a checklist format (level 3); the
other ten studies implemented a higher SR level (≥level 4).
Some studies described a two-step process of implementing
SR level 4 or higher [6, 18, 23–25, 31, 35, 42, 47]. The SR
modules were based on different guidelines, the College of
American Pathologists (CAP; n = 12), the Royal College of
Pathologists (RCP; n = 9) and other guidelines (n = 5). Some
SR modules were based on expert opinion of a pathologist
(n = 7).
Completeness of pathology reports
Overall completeness
Out of the 14 studies [21, 23–25, 28, 30, 32, 33, 36, 38, 40,
45–47] that reported the effect of SR on the overall complete-
ness of a pathology report, 13 showed an increased overall
completeness, for several cancer types and SR levels
(Fig. 2). SR was associated with an increased probability of
providing information on the mandatory parameters [23–25]
and a decrease in the number of missing parameters in a pa-
thology report [36, 48]. The study that failed to show im-
proved completeness [33] commented on the restricted list
of parameters in the SR as defined by CAP. For example, in
the guidelines as defined by CAP, SR description of specimen
type lacked specific histological codes, whereas in NR, these
histological codes could be included.
Parameter-specific completeness
Five studies described the impact of SR on parameter-
specific completeness in breast cancer. Four studies de-
scribed the implementation of SR level 3 (Table 2). The
results of the fifth article of Branston et al. [28], which
implemented SR level 4, were calculated as the percentage
change in minimum dataset completeness; these data are
excluded from the table. ‘Tumour type’ and ‘lymph node
status’ were already reported sufficiently in NR. The
‘oestrogen receptor’ and ‘progesterone receptor’ were al-
ready reported sufficiently in NR according to two studies
[19, 40], but for another study, implementation of SR was
needed to achieve a sufficient reporting [41]. McEvoy et al.
reported increased completeness of the oestrogen receptor
from 84 to 99 %; however, a decrease was seen for the
progesterone receptor [41]. The implementation of SR led
to an increased completeness of four parameters (‘resection
margins’, ‘DCIS size’, ‘location: quadrant’ and ‘calcifica-
tion’). Three parameters increased significantly in the ma-
jority of the studies ‘histological grade’ [19, 23, 40, 41],
‘lymphovascular invasion’ [19, 23, 41] and ‘lesion size’
[19, 23] or already showed sufficient completeness in NR
[19, 40]. The parameters ‘distance tumour to resection
margin’, ‘type of specimen’, ‘location side’, ‘multiple tu-
mour foci’ and ‘CIS in specimen’ showed diverse results;
in some studies, the parameters were already sufficiently
reported in NR, whilst in other studies, implementation of
SR was necessary.
Fourteen studies on SR of colorectal cancer described a
quantitative effect on parameter-specific completeness. Of
these 14 studies, 13 are represented in Table 3. For colorectal
cancer, we merged colon and rectal cancer data if reported
separately. The results of the 14th article by Branston et al.
[28], which implemented SR level 4, were calculated as the
percentage change in minimum dataset completeness. These
were excluded from the table. Nine studies described the ef-
fect of implementing SR level 3, and five studies described the
effect of implementing SR level 4 or higher. Four individual
parameters were already reported sufficiently in NR (tumour
type (Fig. 3a), ‘depth of invasion’, ‘total lymph nodes’ and
‘lymph nodes with metastasis’). ‘Tumour size’ was adequate-
ly reported in the NR of three studies [18, 42, 46] but lacking
in a fourth [21]. ‘Histological grade’ was sufficiently reported
in the majority of studies (n = 9) but not in three other studies
[26, 28, 36]. The completeness of both parameters was in-
creased to 96–100 % after the introduction of SR. The imple-
mentation of SR led to increased completeness for the
reporting of the ‘circumferential resection margin’ (Fig. 3b),
‘distant resection margins’, ‘perineural invasion’ and ‘vascu-
lar and lymphovascular invasion’. The parameters ‘stage’, ‘re-
section margin’ and ‘nodal status’ showed diverse re-
sults; in some studies, NR was already very good, whilst
in other studies, the implementation of SR was
necessary.
Eight studies on SR described other cancer types, as shown
in the tables (Online resources 2–6). Common parameters
‘tumour size’, ‘histological type’ and ‘histological grade’were
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already reported sufficiently in NR, whereas for ‘resection
margins’ and ‘(lympho)vascular/perineural invasion’,
implementation of SR was necessary for an increased com-
pleteness to 96–100 %.
Fig. 1 Flowchart of search
strategy
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Quality of pathology evaluation
Implementation of SR is also expected to affect the quality of
pathology evaluation. One aspect of quality is the accurate
ascertainment of nodal tumour metastasis. If more lymph
nodes are being resected, the N stage will be reported more
accurately. For colorectal cancer, it is advised internationally
to resect at least 12 lymph nodes [53]. The mean number of
Table 1 Characteristic of included studies
Article Country Cancer type Number of
subjects (n)
Study design
(CC or CS)
Level synoptic
reporting
Origin guidelines
Before Step 1 Step 2
Appleton [23] UK Breast 40 CS 1 2 3 NHSBSP
Aumann [24] Germany Prostate 1049 CS 1 3 5 CAP
Aumann [25] Germany Lung 878 CS 1 3 5 CAP
Austin [19] Australia Breast 402 CS 1 3 – ACN
Beattie [26] Ireland Colorectal 171 CC 1 3 – RCP
Branston [28] UK Breast and colorectal 2042 CC 1 4 – RCP
Buchwald [29] Sweden Colon 302 CC 1 3 – Own
Casati [30] Norway Colorectal 1221 CC 1 1 and 5 – RCP
Chan [18] Canada Colorectal 407 CS 1 3 4 CAP
Cross [31] UK Colorectal 272 CS 1 2 3 RCP
Gill [20] Australia Pancreatic 177 CC 1 3 – CAP
Hammond [32] USA Breast 796 CS 1 3 – Own
Hassel [33] USA Breast, prostate and
melanoma
368 CC 1 4 – CAP
Haugland [34] Norway Colorectal 650 CS 1 5 – RCP
Haydu [35] Australia Melanoma 3784 CS 1 3 1 and 3 2008 Melanoma
Guidelines
Idowu [36] USA Breast, colorectal and
prostate
2125 CS 1 3 – CAP
Ihnat [37] Czech Republic Colorectal 177 CC 1 3 – CAP
Kahn [38] Australia Thyroid 448 CS 1 3 – RCPA
Karim [39] Australia Melanoma 1692 CC 1 3 – Own
Mathers [40] UK Breast 100 CC 1 3 – RCP
McEvoy [41] Australia Breast 1649 CS ? 3 – NHMRC
Messenger [42] Canada Rectal 498 CS 1 3 6 CAP
Porter, 2013 [43] Canada Rectal 197 CS 1 3 – Own
Reid, 2000 [44] UK Uterine and cervix 349 CS 1 3 – Own
Renshaw, 2014 [45] USA All synoptic pathology
reports
6193 CS 1 2 3 CAP
Rigby, 2000 [46] UK Colorectal 98 CS 1 3 – RCP
Siriwardana [21] Sri Lanka Colorectal 168 CS 1 3 – RCP
Srigley [47] Canada Breast, lung,
endometrium,
colorectal, and prostate
7594 CS 1 3 6 CAP
Srigley [6] Canada Colorectal and prostate All reports CS 1 3 6 CAP
Ventura [48] Italy Prostate 70 CC 1 3 – CAP
Westgaard [49] Norway Pancreatic 506 CS 1 3 – Own
Westgaard [50] Norway Pancreatic 218 CS 1 3 – Own
Woods [51] UK Colorectal 953 CS 1 3 – RCP
UK United Kingdom, USA United States of America, CC case-control, CS cross sectoral, NHSBSP National Health Service Breast Screening
Programme, CAP College of American Pathologists, ACN Australian Cancer Network, RCP Royal College of Pathologists, RCPA Royal College of
Pathologists Australasia, NHMRC National Health and Medical Research Council
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lymph nodes identified in the surgical specimen for colorectal
cancer was evaluated in 5 of the 14 included studies [18, 29,
37, 46, 51]. All studies showed improvement in mean number
of lymph nodes after implementation of SR (Fig. 3c), and
Fig. 2 Impact of synoptic reporting on overall completeness of a
pathology report. Fourteen studies [21, 23–25, 28, 30, 32, 33, 36, 38,
40, 45–47] reported the effect of synoptic reporting on the overall
completeness of a Pathology report (definition 1). Thirteen studies
showed an increased overall completeness, independent of cancer type
or synoptic reporting level of the module. In contrast, only one article [33]
described that the SR was less complete than the NR
Table 2 Parameter-specific
completeness of the breast cancer
pathology report
Article Appleton [23] Austin [19] Mathersa [40] McEvoy [41]
Level SR Level 3 Level 3 Level 3 Level 3
Origin Guideline NHSBSP ACN RCP NHMRC
Reporting format NR SR NR SR NR SR NR SR2 SR
Number of reports 30 10 95 307 50 50 385 584 680
Individual parameters (%)
Lesion size 63.3 100* 98.9 100 80 88
Tumour type 93.3 100 97.9 100 100 98 100 100 100
Histological grade 70 100* 86.3 100* 96 100 50.1 86.1 97.5*
Lymph node status 100 100 100 99.6 100 100 100 100 100
Resection margins 80 100 89.5 96.1* 93.2
Lymphovascular invasion 70 100 89.5 99.7* 98 98 31.2 66.8 96.9*
CIS in specimen 80 100* 95.8 98.1 84 100* 100 95.7 99.7
DCIS size 23.67 100* 43.9 65.9
Type of specimen 46.67 100* 100 100
Location, side 43.33 100* 100 100
Location, quadrant 76.67 100* 30.5 46.6*
Multiple tumour foci 22.1 74.3* 98.2 97.4 100
Calcification 36.8 91.9* 82 100
ER status 94.5 94.1 90 100 83.9 67.6 98.7*
PR status 93.4 88.5 90 98 83.6 67.3 71.8*
NHSBSP National Health Service Breast Screening Programme, ACN Australian Cancer Networ, RCP Royal
College of Pathologists, NHMRC National Health and Medical Research Council, NR narrative report, SR syn-
optic report; SR2 approximately 50 % reported synoptically, ER oestrogen receptor, PR progesterone receptor
*Significant improvement in completeness according to the article
aMastectomy and biopsy merged together
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more frequently, the minimum number of 12 lymph nodes was
achieved. Three studies also showed an improvement of the
proportion of pathology reports with a minimum of 12 lymph
nodes reported after implementation of SR (Fig. 3d).
Discussion
In this systematic review, we showed that SR results in more
complete pathology reports. Whilst traditional parameters
such as ‘tumour type’, ‘grade’, ‘invasion depth’ and ‘nodal
status’ are in general well reported with NR, other clinical
relevant features such as resection margins and ‘type of local
spread (vascular, lymphovascular and perineural invasion)’
are frequently lacking. The introduction of SR results in im-
proved reporting of these parameters. SR also improves the
mean number of lymph nodes reported and the proportion of
pathology reports with 12 or more lymph nodes [53].
Besides these favourable quantitative outcomes, patholo-
gists found that SR was quick and easy to complete and that
reports included all essential parameters [28]. Even though SR
appears to be more time-consuming in the beginning, imple-
mentation actually resulted in a significant reduction time
spent on the production of the report by pathologists [54,
55]. For multidisciplinary meetings, both pathologists and
clinicians appreciated consistency of the reports [56].
Necessary information for patient management was quick
and unambiguous to find [28, 56].
SR can be implemented in different ways. In the studies
included in the present review, the following six different im-
plementation strategies were described: combined implemen-
tation of SR with clinical audits [23, 31, 47], organisation of
SR education or meetings [18, 28, 32, 37], attachment of SR
hard copy to the request form of the resection specimen [21,
31, 44], addition of explanatory notes to the SR [20, 24],
mandated inclusion of essential parameters according to
guidelines [33, 36, 51] or introduction of the SR module with-
out any special attention [19, 26, 29, 30, 38, 41, 42, 46]. The
implementation strategy could partially explain the success of
implementation of SR. Srigley et al. described the implemen-
tation of SR in Ontario, Canada, where pilots and audits were
used to ensure proper implementation of SR. In 2012, they
achieved successful implementation in 92% of all hospitals in
Ontario [6]. In addition, funding for hospitals, as was used in
Ontario [6, 47], could also have added to the successful im-
plementation of SR.
To date, SR has not been widely adopted in anatomic pa-
thology reporting. The main barriers preventing successful
implementation are the personal preference of pathologists,
who like the flexibility and work flow of NR [57]. Whilst
Fig. 3 Impact of synoptic reporting on individual parameters in a
colorectal specimen pathology report. a The effect of synoptic reporting
on the proportion of pathology reports containing information on tumour
type in colorectal cancers. b The effect of synoptic reporting on the
proportion of pathology reports containing information on circumferential
margin in rectal cancers. c The effect of synoptic reporting on the absolute
mean number of lymph nodes resected per resection specimen. d The effect
of synoptic reporting on the proportion of pathology reports reported 12 or
more lymph nodes resected
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indeed initially, introduction is likely to disrupt the work flow,
this seems a temporary situation. Flexibility is sometimes nec-
essary to express uncertainty about a diagnosis; this can in
most cases be solved by addition of free text fields to a SR.
For instance, Hassel et al. [58] reported that pathologists found
the SR more difficult and inflexible and they missed parame-
ters. Another factor hampering implementation is the intro-
duction of the new reporting format in existing work environ-
ments, such as the electronic patient files and software sys-
tems used throughout the hospital [57, 59]. As reported by
Bjugn et al. [27], the development of the SR in Norway was
delayed considerably because of alterations in the mandatory
diagnostic criteria of the SR and because of alterations in the
user interface for the SR.
There are some potential limitations to our study. We are
confident that with our search, we found the majority of pub-
lished papers, minimising the risk of selection bias. However,
publication bias may cause an overrepresentation of positive
study outcomes.
All studies in this review were observational. The design
was either case-control or cross-sectional. No randomised
controlled trial has been conducted on the effect of SR on
pathology reporting. However, in our opinion, a retrospective
study is suitable to investigate the effect of SR in practice.
Eight studies reported the effect of SR in less than 200 reports
[20, 21, 23, 37, 40, 43, 46, 48]; this is partly due to manually
auditing the data for completeness. Preferably, future studies
would include much higher number of pathology reports to
get a better understanding of the impact of SR on pathology
reporting. The fact that these studies cover different tumour
types and are conducted in different countries and continents
increases the generalisability. Even thoughmost articles inves-
tigated the effect of breast and/or colon cancer, we expect that
the results reported in this review are transferable to imple-
mentation of SR for other cancer types and countries not yet
investigated.
Based on the current data, we can conclude that SR
results in improved reporting of clinical relevant data.
For this reason, it is our opinion that SR is already at
present the best clinical practice for anatomic pathology
cancer reporting. Ongoing innovation in SR software will
likely further improve the value of SR in anatomic pa-
thology, as well as improve the ease of use and efficien-
cy of reporting with SR modules.
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